Drug Testing and Analysis · 2021 · 40 citations · 29 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryPsychopharmacologyStructure-activity RelationshipsCannabinoid PharmacologyChemical Library DesignLigand BindingStructure-activity Relationship AnalysisAnalytical CharacterizationCannabinoid AgonistsCannabinoid Receptor PharmacologyCannabinoid Structure-activity RelationshipsIndazole SynthesisNew Psychoactive Substances IdentificationPharmacological Profiling
Abstract Synthetic cannabinoid receptor agonists (SCRAs) are one of the largest and most structurally diverse classes of new psychoactive substances (NPS). Despite this, pharmacological data are often lacking following the identification of a new SCRA in drug markets. In this first of a three‐part series, we describe the synthesis, analytical characterization, and binding affinity of a proactively generated, systematic library of 30 indole, indazole, and 7‐azaindole SCRAs related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA featuring a 4‐pentenyl (4en‐P), butyl (B/BUT), or 4‐cyanobutyl (4CN‐B/BUT) tail and a methyl l ‐valinate (MMB), methyl l ‐ tert ‐leucinate (MDMB), methyl l ‐phenylalaninate (MPP), l ‐valinamide (AB), l ‐ tert ‐leucinamide (ADB), l ‐phenylalaninamide (APP), adamantyl (A), or cumyl head group. Competitive radioligand binding assays demonstrated that the indazole core conferred the highest CB 1 binding affinity ( K i = 0.17–39 nM), followed by indole‐ ( K i = 0.95–160 nM) and then 7‐azaindole‐derived SCRAs ( K i = 5.4–271 nM). Variation of the head group had the greatest effect on binding, with tert ‐leucine amides and methyl esters ( K i = 0.17–14 nM) generally showing the greatest affinities, followed by valine derivatives ( K i = 0.72–180 nM), and then phenylalanine derivatives ( K i = 2.5–271 nM). Adamantyl head groups ( K i = 8.8–59 nM) were suboptimal for binding, whereas the cumyl analogues consistently conferred high affinity ( K i = 0.62–36 nM). Finally, both butyl ( K i = 3.1–163 nM) and 4‐cyanobutyl ( K i = 5.5–44 nM) tail groups were less favorable for CB 1 binding than their corresponding 4‐pentenyl counterparts ( K i = 0.72–25 nM).
29
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua, Kiran Vemuri, Mengchen Pu et al. · Cell · 2016 · 678 citations · Full text
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar, Moran Shalev-Benami, Michael J. Robertson et al. · Cell · 2019 · 448 citations · Full text
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao, Jie Yin, Karen Chapman et al. · Nature · 2016 · 422 citations · Full text
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li, Tian Hua, Kiran Vemuri et al. · Cell · 2019 · 405 citations · Full text